Speaker illustration

undefined undefined undefined

Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism

Event: ESC Congress 2019

Topic: Health Economics

Session: Health economics and policy

Thumbnail

ESC 365 is supported by